Borden Chemical, Inc. has filed a registration statement, which is not yet effective, with the U.S. Securities and Exhange Commission (SEC) for a proposed public offering of its common stock. Shares will be sold by a selling stockholder of the company, Borden Holdings, LLC, an affiliate of Kohlberg Kravis Roberts & Co. Borden Chemical will not receive any proceeds from the sale of shares by the selling stockholder. Credit Suisse First Boston LLC and Morgan Stanley & Co. Inc. are serving as joint book-running managers for the offering. Copies of the preliminary prospectus related to the offering, when available, may be obtained from the SEC by writing to the Public Reference Section at 450 Fifth Street NW, Washington, DC 20549, or by visiting .